Joe Stone, a member of Cargill’s executive team, chief risk officer and the leader of the company’s animal nutrition business, has been elected to the company’s board of directors.
“Joe’s leadership at Cargill is distinguished by his strong focus on customers, innovation and delivering results,” said David MacLennan, chairman and chief executive officer. “Since joining our company 31 years ago, he has demonstrated an unwavering commitment to developing people and a culture of teamwork and high performance. He led two of our company’s most significant acquisitions: the $2 billion purchase in 2011 of Provimi, a global animal nutrition company, followed in 2015 by the $1.6 billion acquisition of EWOS, a global provider of salmon nutrition. Joe’s strategic vision, track record of performance and dedication to people make him an excellent addition to the Cargill board.”
Stone joined Cargill in 1985 and held various management positions in the company’s agricultural supply chain and global trading businesses in the United States and Switzerland until 2005. At that time, he joined the animal nutrition leadership team and in the following years oversaw the business’s global growth.
Stone is a member of the board of the Engler School of Entrepreneurial Studies at the University of Nebraska, a member of the Campaign for Nebraska Advisory Board, and serves on the University of Minnesota’s Carlson School of Business Board of Overseers.
He received a bachelor’s degree in agricultural economics from the University of Nebraska.
Stone joins 15 other members on Cargill’s board, including independent directors Richard H. Anderson, retired chairman of Delta Air Lines, Inc.; Louis R. Chênevert, retired chairman and CEO of United Technologies Corp.; Arthur D. Collins Jr., retired chairman and CEO of Medtronic, Inc.; Stephen J. Hemsley, CEO of UnitedHealth Group; Bernard Poussot, retired chairman, CEO and president of Wyeth; and Trudy Rautio, retired president and CEO of Carlson.
Source: World Grain
The company expects to eliminate 1.2 billion tons carbon dioxide equivalent of methane emissions by the end of the decade. The company says that it already reduced its methane emissions by around 14% between 2018 and 2020.
The “first-of-its-kind” pilot project will develop and demonstrate an affordable modular bioprocessing system to produce biodegradable bioplastics from food waste diverted from landfills. The three-year grant will test the scalability and feasibility of the conversion on a national and global scale.
Arkeon is allying with specialty mineral giant ICL to support the scaling of its fermentation bioprocess that converts CO2 into the 20 proteinogenic essential amino acids needed in human nutrition. The process, hailed as carbon negative, is based on the use of archaea, a group of microorganisms that naturally feeds off the greenhouse gas.